Blood Neoplasia
Издатель: Elsevier · ISSN 2950-3280 · 90 статей
- AML/MDS patients with DDX41 (DEAD-box helicase 41) germline variants: A single-center experience
- Prospective Analyses of the Utility of Liquid Biopsy in Patients with Fever of Unknown Origin Suspected of Lymphoma
- Prognostic and Serial Assessment of Functional/Psychosocial Factors in Older Adults Receiving AML Induction Chemotherapy
- Disrupting RNA Splicing Sensitizes T-ALL Cells to Proteasome Blockade
- Out-of-frame but not out-of-function: cryptic mRNA splicing in FLT3 internal tandem duplications
- Resistance to CD20×CD3 Bispecific Antibodies in B-Cell Lymphoma: Mechanisms and Emerging Therapeutic Strategies
- Unmasking BCL2A1: IL10/STAT3-Driven BCL2A1 Expression Promotes Apoptosis Resistance in DLBCL
- Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma
- Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia
- Targeted Therapy Yields Early Neurologic Improvement in Central Nervous System Histiocytic Neoplasms
- Safety Outcomes of First-Line Venetoclax vs Second-Generation BTKi in CLL/SLL: A Retrospective Cohort Study
- Lineage switch in leukemia and lymphoma: case reports and molecular and cellular mechanisms
- Exercise and nutrition in hematologic malignancies: translational evidence and emerging interventions
- Longitudinal patient-reported outcomes and quality-of-life trajectories over 2 years in CAR-T therapy recipients
- Tamibarotene with venetoclax and azacitidine in RARA+ acute myeloid leukemia: results from the SY-1425-202 study
- Deuterium labeling uncovers deregulated myeloid cell kinetics in chronic myelomonocytic leukemia
- Favezelimab plus pembrolizumab for anti–PD-1–refractory classic Hodgkin lymphoma: an open-label phase 1/2 study
- Treatment preferences in Waldenström macroglobulinemia: an international discrete choice experiment in 1455 patients
- Targeting ROR1 with KAN571C disrupts resistance networks in mantle cell lymphoma
- Survival benefit of chemoradiotherapy in limited-stage mantle cell lymphoma: a National Cancer Database analysis
- Excess body weight at diagnosis is associated with inferior ALL outcomes in male adolescents in the ALL-BFM 2000 study
- Single-cell sequencing reveals transcriptional and immunogenetic diversity in stereotyped chronic lymphocytic leukemia
- IMiD/CELMoD resistance in myeloma is associated with changes in lipid metabolism that may be targetable
- Real-world outcomes of mosunetuzumab use in relapsed/refractory indolent lymphomas: a CUBIC consortium analysis
- Racial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma
- Dose-modified methotrexate, rituximab, and temozolomide induction achieves durable remissions in PCNSL
- Impact of body composition on toxicity and response in patients with advanced-stage Hodgkin lymphoma treated with BV-AVD
- A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma
- Refining risk in historically high-risk pediatric B-cell acute lymphoblastic leukemia: response kinetics and outcomes
- Travel time, insurance, and specialized cancer care for adolescents and young adults with acute lymphoblastic leukemia